Reuters logo
2 个月前
BRIEF-SciClone to be acquired by consortium led by GL Capital
2017年6月8日 / 上午10点34分 / 2 个月前

BRIEF-SciClone to be acquired by consortium led by GL Capital

1 分钟阅读

June 8 (Reuters) - Sciclone Pharmaceuticals Inc

* SciClone enters into definitive merger agreement to be acquired by consortium led by GL Capital

* SciClone Pharmaceuticals Inc - deal for 11.18 per share

* SciClone Pharmaceuticals Inc - deal for ‍approximately $605 million​

* Transaction, which was unanimously approved by SciClone's board, values company at approximately $605 million

* SciClone Pharmaceuticals Inc - transaction will be funded by buyer consortium through a combination of equity financing

* Says Lazard is serving as exclusive financial advisor to SciClone and DLA Piper LLP (US) is serving as its legal advisor

* Transaction was unanimously approved by SciClone's board

* SciClone Pharmaceuticals Inc - transaction will also be funded by consortium through debt financing, and is not subject to a financing condition Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below